iHuman Inc. Reports Q1 2025 Revenue Decline to RMB210.4 Million, Net Income Rises to RMB26.5 Million

Reuters
Yesterday
iHuman Inc. Reports Q1 2025 Revenue Decline to RMB210.4 Million, Net Income Rises to RMB26.5 Million

iHuman Inc. $(IH)$, a leading provider of tech-powered intellectual development products in China, has announced its unaudited financial results for the first quarter ended March 31, 2025. The company reported revenues of RMB210.4 million (US$29.0 million), a decrease from RMB235.0 million in the same period last year. Gross profit for the quarter was RMB143.8 million (US$19.8 million), down from RMB168.1 million in the previous year. Despite the decline in revenue and gross profit, iHuman Inc. saw an increase in operating income, which reached RMB21.6 million (US$3.0 million), compared to RMB17.5 million in the same period last year. Net income also rose to RMB26.5 million (US$3.7 million) from RMB22.3 million a year ago. The average total monthly active users (MAUs) for the first quarter were 26.51 million, slightly up from 26.38 million in the same period last year. The company did not provide specific outlook or guidance in the current document.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iHuman Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN19178) on June 26, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10